Plus Therapeutics Announces Private Placement Financing of up to $18 Million
May 06, 2024 07:30 ET
|
Plus Therapeutics Inc.
Plus Therapeutics Announces Private Placement Financing of up to $18 Million
Dime Announces Expansion in Williamsburg With Deposit-Focused Group
May 06, 2024 07:30 ET
|
Dime Community Bancshares, Inc.
HAUPPAUGE, N.Y., May 06, 2024 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”), announced that it...
Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences
May 06, 2024 07:30 ET
|
Ocular Therapeutix, Inc.
BEDFORD, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to enhancing people’s vision and quality of...
Quipt Home Medical Corp. to Announce Fiscal Second Quarter 2024 Financial Results on May 15, 2024
May 06, 2024 07:30 ET
|
Quipt Home Medical Corp.
CINCINNATI, May 06, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory...
Allot Announces the Appointment of Eyal Harari as Chief Executive Officer
May 06, 2024 07:22 ET
|
Allot
Hod Hasharon, Israel, May 06, 2024 (GLOBE NEWSWIRE) -- Allot Ltd. (NASDAQ: ALLT, TASE: ALLT), a leading global provider of innovative network intelligence and security solutions for service...
SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors
May 06, 2024 07:15 ET
|
SAB Biotherapeutics, Inc.
MIAMI, May 06, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform developing a human...
N2OFF: Save Foods to Target California’s Hemp Market
May 06, 2024 07:13 ET
|
N2OFF Inc.
More than half of US hemp flower grown in California recently received Pre-Harvest Regulatory Approval in California allowing Save Foods to treat hemp Neve Yarak, Israel, May 06, 2024 (GLOBE...
Skyward Specialty Announces Secondary Offering of Its Common Stock
May 06, 2024 07:12 ET
|
Skyward Specialty Insurance Group, Inc.
HOUSTON, May 06, 2024 (GLOBE NEWSWIRE) -- Skyward Specialty Insurance Group, Inc. (NASDAQ: SKWD) (“Skyward Specialty” or the “Company”) a leader in the specialty property and casualty (“P&C”)...
Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
May 06, 2024 07:00 ET
|
Omega Therapeutics
Advanced MYCHELANGELO™ I trial dose escalation to Cohort 5; Presentation of additional monotherapy data and planned expansion into Phase 2 settings expected in mid-2024Presented new preclinical data...
BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update
May 06, 2024 07:00 ET
|
BioCryst Pharmaceuticals, Inc.
—Q1 2024 ORLADEYO net revenue grows 30 percent y-o-y to $88.9 million— —Full-year 2024 ORLADEYO revenue guidance adjusted to $390-$400 million (top end of prior guidance range) — —Pipeline programs,...